Eclanamine (U-48753) is a drug which was patented as an antidepressant but was never marketed. It acts by inhibiting the reuptake of serotonin and norepinephrine. Eclanamine was discovered by accident as a derivative of the κ-opioid receptor agonist U-50488.
This page contains content from the copyrighted Wikipedia article "Eclanamine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
